ClearPoint Neuro(US:CLPT)2024-05-07 22:37Company Overview - ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine[9] - The company leverages live MR imaging for precise guidance with sub-millimetric accuracy[11] - ClearPoint Neuro has over 50 biotech and pharma partners, with an established quality system and custom device development[10] - The company estimates a total addressable market (TAM) of over $12 billion across 35+ indications and 50+ partners[10] Products and Services - ClearPoint Neuro offers translational pre-clinical, clinical trial, and regulatory services[6] - The company has an FDA-cleared second-generation laser therapy system[6] - The ClearPoint Neuro Navigation System has been used in over 7,000 procedures[6, 51] Financials and Growth - The company's revenue guidance for 2024 is $28.0 - $32.0 million[34] - The company is expanding its global footprint, aiming for 100+ centers[42, 50] Strategic Focus - The company's strategy includes expanding into the operating room with ClearPoint OR and showing compatibility with existing third-party navigation systems[43] - ClearPoint Neuro aims to expand neuro pre-clinical CRO services and capacity, including GLP capability[43] - The company is developing a pipeline for drug infusion monitoring/modeling, intracranial cell therapy, and spinal routes of administration[43]